spacer
home > white papers > Utilising Big Data to Produce Faster and Cheaper Clinical Research - Medical Research Network (MRN) Limited
WHITE PAPERS
logo_Medical_Re.JPG

Medical Research Network (MRN) Limited

phone +44 (0) 1908 261 153
email Enquiries@themrn.co.uk
web http://www.themrn.co.uk/
email Talon House, Presley Way, Milton Keynes, Buckinghamshire, MK8 0ES

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

At Pharmapack Paris, TekniPlex to Showcase Cleanroom-produced COC Films, Among Other Solutions

Wayne, PA – At Pharmapack Paris, February 1-2, TekniPlex, a globally integrated provider of innovative solutions through materials science and manufacturing technologies, will showcase samples from a range of cyclic olefin copolymer (COC) diagnostics films whose cleanroom production is a differentiator in the healthcare space. At booth B96-98, the company also will highlight another recently introduced innovation: the world’s first fully transparent recyclable mid-barrier blister package.
More info >>


White Papers

Future-proofing serialization solutions: the importance of strong level 3 capabilities

Adents

The complexities surrounding product serialization for pharmaceutical and medical device companies are immense. While current serialization requirements are limited to marking the unit of sale with a unique data carrier, by 2023 the process will require a product to be traceable through the entirety of its journey - from the individual package through the carton/pallet to its final point of distribution. In the United States, the Healthcare Distribution Management Association (HDMA) is suggesting that pharmaceutical companies begin to support this level of serialization, called aggregation, now. Around the world – in Europe and Asia in particular – disparate track and trace practices are incrementally moving toward a global standard that will, undoubtedly, be more stringent than today’s differing benchmarks. How can companies manage this transformation with the greatest degree of success while also minimizing business disruption? The key to creating an optimal implementation strategy is to select a serialization solution that has strong capabilities at all levels of technology. It’s also important to choose a solution that enables multi-phase implementation
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement